Ip Group Share Price (IPO)

Further details about game-changer Lampore test kit developed by Oxf Nanopore, published after market close.

https://www.dailymail.co.uk/news/article-8349083/New-coronavirus-test-gives-results-hour-start-mass-screening-weeks.html

@Foxrod, I agree with you that buying IPO is worth the price for Nanopore alone, the balance sheet cash and the other 100+ biotech and tech holdings are a bonus. Given the biotech frenzy going on now, a listing for Oxf Nanopore looks pretty likely in 2020/2021 now that they can show off impressive and growing revenues.

There have been a number of positive developments within IPO's portfolio recently and they have already realised more cash than last year. In time I think we will see the SP uprated but investing in IP certainly needs a lot of patience. I'm underwater with IPO but added around 50p and may do so again as I feel strongly that it is investing in some interesting areas and is undervalued. In my view Oxford Nanopore alone has the potential to account for IPO's entire current market cap. We will have to wait and see if and how much further Invesco reduce their stake but they may now be close to a percentage they are comfortable.

Telegraph article today:
Oxford Nanopore develops Covid-19 test system that can process 30,000 samples a day
https://www.telegraph.co.uk/technology/2020/05/22/oxford-nanopore-develops-covid-19-test-system-can-process-30000/

@DD77 I agree that Invesco probably want rid of everything vaguely associated with the now toxic Woodford brand. But they could've dumped much larger chunks of the IPO holding sooner before the big fall in March. The steady decline in their holding suggests to me the sales are being driven by fund redemptions from their tainted Income fund. Now Barnett has gone perhaps investors will give Invesco another chance.